VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASH 2019 | Elderly DLBCL updates

Graham Collins • 7 Dec 2019
ASH 2019
Anemia B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Cyclophosphamide Doxorubicin Lenalidomide Prednisone Vincristine

Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, shares his highlights from the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL. Dr Collins specifically discusses news relating to elderly patients with diffuse large B-cell lymphoma (DLBCL).

More from Graham Collins

1:14
Checkmate 205 study results: nivolumab in classical Hodgkin Lymphoma
Graham Collins • 16 Apr 2018
2:27
Ones to watch: lymphoma trials
Graham Collins • 20 Jun 2019
1:32
CAR T-cell therapy: the importance of LTFU
Graham Collins
1:41
ECHELON-1 AYA subgroup results: brentuximab vedotin plus AVD vs. ABVD
Graham Collins

Related Videos

2:54
Waldenström’s therapy: what's on the horizon?
Jorge Castillo • 16 Apr 2021
3:46
Current state of the art for WM
Jorge Castillo • 16 Apr 2021
4:07
Challenges associated with Waldenström’s
Jorge Castillo • 16 Apr 2021
3:49
Genomic landscape of Waldenström’s
Jorge Castillo • 16 Apr 2021
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals